Related references
Note: Only part of the references are listed.Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate
Joanna L. Fox et al.
NATURE COMMUNICATIONS (2021)
Long non-coding RNA NEAT1 regulates endothelial functions in subclinical hypothyroidism through miR-126/TRAF7 pathway
Li Wang et al.
HUMAN CELL (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Long and short isoforms of c-FLIP act as control checkpoints of DED filament assembly
Laura K. Hillert et al.
ONCOGENE (2020)
Dissecting DISC regulation via pharmacological targeting of caspase-8/c-FLIPL heterodimer
Laura K. Hillert et al.
CELL DEATH AND DIFFERENTIATION (2020)
Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury
Raanan Bulvik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma
Yu-Peng Liu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
cFLIPL protects macrophages from LPS-induced pyroptosis via inhibition of complex II formation
Hayley I. Muendlein et al.
SCIENCE (2020)
Controlling Cell Death through Post-translational Modifications of DED Proteins
Kamil Seyrek et al.
TRENDS IN CELL BIOLOGY (2020)
Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics
Jouliana Sadek et al.
NATURE COMMUNICATIONS (2020)
Overexpression of miR-382 Sensitizes Hepatocellular Carcinoma Cells to γδ T Cells by Inhibiting the Expression of c-FLIP
Zhong Chen et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
SIRT1 Deficiency, Specifically in Fibroblasts, Decreases Apoptosis Resistance and Is Associated with Resolution of Lung-Fibrosis
Raanan Bulvik et al.
BIOMOLECULES (2020)
The pseudo-caspase FLIP(L) regulates cell fate following p53 activation
Andrea Lees et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Pharmacological targeting of c-FLIPL and Bcl-2 family members promotes apoptosis in CD95L-resistant cells
Corinna Koenig et al.
SCIENTIFIC REPORTS (2020)
WP1130 Enhances TRAIL-Induced Apoptosis through USP9X-Dependent miR-708-Mediated Downregulation of c-FLIP
Seok Kim et al.
CANCERS (2019)
Delineating the role of c-FLIP/NEMO interaction in the CD95 network via rational design of molecular probes
Nikita V. Ivanisenko et al.
BMC GENOMICS (2019)
Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways
Kamil Seyrek et al.
CELL DEATH AND DIFFERENTIATION (2019)
Polyamino Acid Layer-by-Layer (LbL) Constructed Silica-Supported Mesoporous Titania Nanocarriers for Stimuli-Responsive Delivery of microRNA 708 and Paclitaxel for Combined Chemotherapy
Biki Gupta et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists
Christopher McCann et al.
CELL DEATH & DISEASE (2018)
USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability
M. Jeong et al.
ONCOGENE (2017)
MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer
Weijiang Zhang et al.
GENE (2017)
IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection
Louise C. Briggs et al.
JOURNAL OF VIROLOGY (2017)
Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain
K. Schleich et al.
CELL DEATH AND DIFFERENTIATION (2016)
Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma
Mei-Chuan Chen et al.
ONCOTARGET (2016)
Molecular basis of death effector domain chain assembly and its role in caspase-8 activation
Nitu Singh et al.
FASEB JOURNAL (2016)
FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer
Kylie A. McLaughlin et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate
Michelle A. Hughes et al.
MOLECULAR CELL (2016)
Cryo-EM Structure of Caspase-8 Tandem DED Filament Reveals Assembly and Regulation Mechanisms of the Death-Inducing Signaling Complex
Tian-Min Fu et al.
MOLECULAR CELL (2016)
Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and Downregulation of FLIP
Jing Liu et al.
TRANSLATIONAL ONCOLOGY (2016)
Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs
Eun-Ae Kim et al.
ONCOTARGET (2016)
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL
Robbie Carson et al.
CLINICAL CANCER RESEARCH (2015)
The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma
Mario Venza et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Role of miR-155 in drug resistance of breast cancer
Dan-dan Yu et al.
TUMOR BIOLOGY (2015)
Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
Zhou Luan et al.
MOLECULAR MEDICINE REPORTS (2015)
Inhibition of Methyltransferases Accelerates Degradation of cFLIP and Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis
Frank K. Braun et al.
PLOS ONE (2015)
Identification and Characterization of the Interaction Site between cFLIPL and Calmodulin
Gabriel Gaidos et al.
PLOS ONE (2015)
Evidence of complex formation between FADD and c-FLIP death effector domains for the death inducing signaling complex
Eun Young Hwang et al.
BMB REPORTS (2014)
Pazopanib and HDAC inhibitors interact to kill sarcoma cells
Seyedmehrad Tavallai et al.
CANCER BIOLOGY & THERAPY (2014)
Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP
Isabella Venza et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors
Zhong Zheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Tom Vanden Berghe et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Systems biology: a way to make complex problems more understandable
I. N. Lavrik et al.
CELL DEATH & DISEASE (2014)
Systems biology of death receptor networks: live and let die
I. N. Lavrik
CELL DEATH & DISEASE (2014)
Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assembly
J. Majkut et al.
NATURE COMMUNICATIONS (2014)
Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemia
Donal McLornan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases
Krithi Rao-Bindal et al.
CURRENT CANCER DRUG TARGETS (2013)
Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer
Simone Fulda
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Novel Phosphorylation and Ubiquitination Sites Regulate Reactive Oxygen Species-dependent Degradation of Anti-apoptotic c-FLIP Protein
Rachel P. Wilkie-Grantham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cells
Hossein A. Hamed et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
Laura Bergada et al.
MOLECULAR ONCOLOGY (2013)
microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma
Nan Ling et al.
ONCOLOGY REPORTS (2013)
Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer
J. S. Riley et al.
CELL DEATH & DISEASE (2013)
SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma
N. Crawford et al.
CELL DEATH & DISEASE (2013)
MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1
Chun-Mei Zhang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis
Hak-Bong Kim et al.
BIOCHEMICAL PHARMACOLOGY (2012)
SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells
M. Lauricella et al.
BIOCHIMIE (2012)
The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
Jixi Li et al.
CELL (2012)
Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis
E. Kerr et al.
CELL DEATH AND DIFFERENTIATION (2012)
Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor-Targeted Therapy
Clare McCourt et al.
CLINICAL CANCER RESEARCH (2012)
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent
Jane L. Hurwitz et al.
EUROPEAN JOURNAL OF CANCER (2012)
Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions
Selcen Oeztuerk et al.
EXPERIMENTAL CELL RESEARCH (2012)
Apoptosis Induction by SAHA in Cutaneous T-Cell Lymphoma Cells Is Related to Downregulation of c-FLIP and Enhanced TRAIL Signaling
Nadya Al-Yacoub et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Reduced CaM/FLIP binding by a single point mutation in c-FLIPL modulates Fas-mediated apoptosis and decreases tumorigenesis
Gu Jing et al.
LABORATORY INVESTIGATION (2012)
A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death
Laura S. Dickens et al.
MOLECULAR CELL (2012)
Stoichiometry of the CD95 Death-Inducing Signaling Complex: Experimental and Modeling Evidence for a Death Effector Domain Chain Model
Kolja Schleich et al.
MOLECULAR CELL (2012)
Kaposi's Sarcoma Associated Herpesvirus Encoded Viral FLICE Inhibitory Protein K13 Activates NF-κB Pathway Independent of TRAF6, TAK1 and LUBAC
Hittu Matta et al.
PLOS ONE (2012)
FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity
Cristina Pop et al.
BIOCHEMICAL JOURNAL (2011)
Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression
M. Bleumink et al.
CELL DEATH AND DIFFERENTIATION (2011)
Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells
Alba Perez-Perarnau et al.
EPIGENETICS (2011)
Modeling Reveals That Dynamic Regulation of c-FLIP Levels Determines Cell-to-Cell Distribution of CD95-mediated Apoptosis
Hannu T. Toivonen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
Maria Feoktistova et al.
MOLECULAR CELL (2011)
Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis
Andrew Oberst et al.
NATURE (2011)
Caspase 8 inhibits programmed necrosis by processing CYLD
Marie Anne O'Donnell et al.
NATURE CELL BIOLOGY (2011)
Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy
Ahmad R. Safa et al.
Cancers (2011)
Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells
Eun-Sil Sung et al.
APOPTOSIS (2010)
Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells
D. Mahalingam et al.
BRITISH JOURNAL OF CANCER (2010)
HDAC inhibitors with different gene regulation activities depend on the mitochondrial pathway for the sensitization of leukemic T cells to TRAIL-induced apoptosis
J. C. Morales et al.
CANCER LETTERS (2010)
Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation
I. Verbrugge et al.
CELL DEATH AND DIFFERENTIATION (2010)
The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients
L-C Chen et al.
CELL DEATH AND DIFFERENTIATION (2010)
Cellular FLICE-inhibitory protein (c-FLIP) signalling: A key regulator of receptor-mediated apoptosis in physiologic context and in cancer
Marina Bagnoli et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Histone deacetylase inhibitor-induced sensitization to TNFα/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression
Katalin Darvas et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL
Nicolai Fricker et al.
JOURNAL OF CELL BIOLOGY (2010)
Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
Tabitha E. Wood et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Dynamics within the CD95 death-inducing signaling complex decide life and death of cells
Leo Neumann et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Molecular mechanisms of necroptosis: an ordered cellular explosion
Peter Vandenabeele et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Inhibition of c-FLIP expression by miR-512-3p contributes to Taxol-induced apoptosis in hepatocellular carcinoma cells
Feng Chen et al.
ONCOLOGY REPORTS (2010)
The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo
David M. Lucas et al.
PLOS ONE (2010)
c-FLIP Degradation Mediates Sensitization of Pancreatic Cancer Cells to TRAIL-Induced Apoptosis by the Histone Deacetylase Inhibitor LBH589
John Kauh et al.
PLOS ONE (2010)
Is TRAIL the holy grail of cancer therapy?
Thomas Newsom-Davis et al.
APOPTOSIS (2009)
Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway
Soo-Jung Park et al.
BIOCHEMICAL PHARMACOLOGY (2009)
A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein
Nana Ueffing et al.
BLOOD (2009)
p63 regulates the caspase-8-FLIP apoptotic pathway in epidermis
S. Borrelli et al.
CELL DEATH AND DIFFERENTIATION (2009)
Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression
J. Y. Zhu et al.
CELL DEATH AND DIFFERENTIATION (2009)
PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability
A. Kaunisto et al.
CELL DEATH AND DIFFERENTIATION (2009)
Involvement of FLIP in 2-Methoxyestradiol-Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate Model
Manonmani Ganapathy et al.
CLINICAL CANCER RESEARCH (2009)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation
Daniela Carlisi et al.
EUROPEAN JOURNAL OF CANCER (2009)
IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway
Guodong Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Expression and biological significance of c-FLIP in human hepatocellular carcinomas
Xilin Du et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Involvement of Extracellular Signal-Regulated Kinase Activation in Human Osteosarcoma Cell Resistance to the Histone Deacetylase Inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone]
Hiroshi Matsubara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Understanding apoptosis by systems biology approaches
Inna N. Lavrik et al.
MOLECULAR BIOSYSTEMS (2009)
Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms
Teneille Walker et al.
MOLECULAR PHARMACOLOGY (2009)
The Fas-FADD death domain complex structure unravels signalling by receptor clustering
Fiona L. Scott et al.
NATURE (2009)
A TNF- and c-Cbl-dependent FLIPS-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis
Manikuntala Kundu et al.
NATURE IMMUNOLOGY (2009)
Mechanism of procaspase-8 activation by c-FLIPL
Jong W. Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling
Pritish S. Pawar et al.
BIOCHEMICAL JOURNAL (2008)
Up-regulation of c-FLIPshort by NEAT contributes to apoptosis resistance of short-term activated T cells
Nana Ueffing et al.
BLOOD (2008)
Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
Margaret A. Park et al.
CANCER BIOLOGY & THERAPY (2008)
Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DISC recruitment
N. Ueffing et al.
CELL DEATH AND DIFFERENTIATION (2008)
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
Ailsa J. Frew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities
Jia Y. Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response
Laurence Lagneaux et al.
EXPERIMENTAL HEMATOLOGY (2007)
Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients
Gustave J. Ullenhag et al.
CLINICAL CANCER RESEARCH (2007)
Life and death in peripheral T cells
Peter H. Krammer et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis
Wei Wang et al.
GYNECOLOGIC ONCOLOGY (2007)
MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L)
Wenhua Li et al.
CANCER RESEARCH (2007)
Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis
J. R. Muppidi et al.
CELL DEATH AND DIFFERENTIATION (2006)
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland
Shen Gao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
The c-FLIP-NH2 terminus (p22-FLIP) induces NF-κB activation
Alexander Golks et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-κB activation
Y Takada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL
A Pathil et al.
HEPATOLOGY (2006)
Influence of TRP53 status on FAS membrane localization, CFLAR (c-FLIP) ubiquitinylation, and sensitivity of CC-2spd (ts) cells to undergo FAS-mediated apoptosis
Y Chandrasekaran et al.
BIOLOGY OF REPRODUCTION (2006)
The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover
LF Chang et al.
CELL (2006)
Crystal structure of a viral FLIP - Insights into FLIP-mediated inhibition of death receptor signaling
FY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort
C Salon et al.
CELL DEATH AND DIFFERENTIATION (2006)
Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein
P Chanvorachote et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition
JK Yang et al.
MOLECULAR CELL (2005)
mTOR controls FLIPs translation and TRAIL sensitivity in glioblastoma multiforme cells
A Panner et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Rapid turnover of c-FLIP short is determined by its unique C-terminal tail
M Poukkula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Novel histone deacetylase inhibitors in the treatment of thyroid cancer
CS Mitsiades et al.
CLINICAL CANCER RESEARCH (2005)
Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-κB activation
A Dohrman et al.
JOURNAL OF IMMUNOLOGY (2005)
c-FLIPR, a new regulator of death receptor-induced apoptosis
A Golks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis
C Xiao et al.
EXPERIMENTAL CELL RESEARCH (2005)
Cross-talk between Fas/Fas ligand system and nitric oxide in the pathway subserving granulosa cell apoptosis: A possible regulatory mechanism for ovarian follicle atresia
QM Chen et al.
ENDOCRINOLOGY (2005)
Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
K Watanabe et al.
CELL DEATH AND DIFFERENTIATION (2005)
Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma
XD Zhou et al.
CLINICAL SCIENCE (2004)
Cotreatment with histone deacetylase inhibitor LAQ824 enhances apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells
F Guo et al.
CANCER RESEARCH (2004)
The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP
C Skurk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis
M Bentele et al.
JOURNAL OF CELL BIOLOGY (2004)
CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma
D Mezzanzanica et al.
CLINICAL CANCER RESEARCH (2004)
Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1
R Tang et al.
LEUKEMIA (2004)
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells
DM Lucas et al.
LEUKEMIA (2004)
c-FLIP expression in bladder urothelial carcinomas: Its role in resistance to FAS-mediated apoptosis and clinicopathologic correlations
P Korkolopoulou et al.
UROLOGY (2004)
Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity
MS Ricci et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Long form of cellular FLICE-inhibitory protein interacts with Daxx and prevents Fas-induced JNK activation
YY Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Mechanisms of caspase activation
KM Boatright et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein
JL Aron et al.
BLOOD (2003)
Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells
BF Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis
H Higuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The long form of FLIP is an activator of caspase-8 at the fas death-inducing signaling complex
O Micheau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
DW Chang et al.
EMBO JOURNAL (2002)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation - Resistance to Fas ligand-induced apoptosis
WL Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin
EC Shin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2002)
Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer
L Boldrini et al.
ONCOGENE (2001)
Regulation of lymphocyte proliferation and death by flip
M Thome et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells
T Fukazawa et al.
ONCOGENE (2001)
Selective expression of FLIP in malignant melanocytic skin lesions
RR Bullani et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
NF-κB signals induce the expression of c-FLIP
O Micheau et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP)
T Suhara et al.
CIRCULATION RESEARCH (2001)
Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different FLIP isoforms
M Djerbi et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
S Kreuz et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Regulation of translation initiation by FRAP/mTOR
AC Gingras et al.
GENES & DEVELOPMENT (2001)
Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells
DJ Panka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells
T Bartke et al.
ONCOGENE (2001)
Ca2+ mobilization induced by W-7 in MG63 human osteosarcoma cells
CR Jan et al.
PHARMACOLOGICAL RESEARCH (2000)